Phacoemulsification system market seen reaching $2.16 billion by 2030

The phacoemulsification system market is projected to grow from $1.63 billion in 2026 to $2.16 billion by 2030, driven by cataract prevalence, aging populations and wider use of minimally invasive eye surgery. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - Phacoemulsification systems are central to cataract surgery, which is one of the most common eye procedures tied to aging populations. - Market growth signals continued demand for surgical tools that support faster recovery, smaller incisions and better patient safety. - The expansion also points to rising investment in ophthalmic infrastructure and advanced eye care technology.

What happened: - The Business Research Company projected the global phacoemulsification system market will rise from $1.51 billion in 2025 to $1.63 billion in 2026. - The same report forecast the market will reach $2.16 billion by 2030. - The report said the market will grow at a 7.6% CAGR from 2025 to 2026 and a 7.3% CAGR through 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Phacoemulsification systems use ultrasonic energy to break up and remove the eye’s natural lens during cataract surgery. - The procedure supports implantation of an artificial intraocular lens to restore vision. - The systems are designed to control fluid flow, pressure and ultrasonic energy during surgery. - Key growth drivers include rising cataract cases, an aging global population, wider adoption of phacoemulsification techniques and expansion of ophthalmic infrastructure. - The report also linked growth to surgeons’ preference for minimally invasive surgical tools. - Supportive factors in the forecast include more outpatient eye surgeries, advances in ultrasound technology, higher demand for premium intraocular lenses, growth in emerging markets and greater awareness of vision care. - The report highlighted trends including advanced fluidics control, minimally invasive cataract surgery, high-precision ultrasonic energy delivery, shorter surgery times and stronger patient safety measures. - In May 2024, Gov.UK reported 516,073 cataract surgery hospital admissions in England among people aged 65 and older in 2023, equal to a rate of 4,679 per 100,000 population. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated graphics and tables. - More information is available in the full report. - A free sample of the report is also available.

Between the lines: - The forecast suggests cataract surgery demand remains structurally tied to demographics, especially population aging. - Faster growth in Asia-Pacific points to broader access to eye surgery and expanding healthcare capacity in emerging markets. - The report’s emphasis on minimally invasive procedures shows the market is shifting toward faster, safer and more precise surgical workflows.

What's next: - The market is expected to keep benefiting from outpatient surgery growth and continued ultrasound innovation through 2030. - Greater adoption of premium intraocular lenses could add another layer of demand for compatible surgical systems. - Manufacturers are likely to compete on fluidics control, precision and safety features as cataract procedures become more standardized.

The bottom line: - Phacoemulsification systems are on track for steady global growth as cataract surgery volumes rise and eye care providers continue moving toward minimally invasive techniques.